Skip to main content

Clara Carnicer Cáceres

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Clara Carnicer Cáceres

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Caracterización clínica de variantes patogénicas e investigación de nuevos factores pronósticos en la nefropatía IgA

IP: -
Collaborators: Manuel Hernández González, David Beneitez Pastor, Clara Carnicer Cáceres, Maria Teresa Salcedo Allende
Funding agency: Instituto de Salud Carlos III
Funding: 90750
Reference: PI10/01055
Duration: 01/01/2011 - 31/12/2013

Related news

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Related professionals

Ana Lain Fernandez

Ana Lain Fernandez

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Rebeca Blanch Garcia

Rebeca Blanch Garcia

Research technician
Gene Therapy at Nervous System
Read more
Jose Maria  Zuazo  Morquecho

Jose Maria Zuazo Morquecho

Liver Diseases
Read more
Leidy Alejandra Gonzalez Molano

Leidy Alejandra Gonzalez Molano

Research technician
Microbiome Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.